Stiefel Laboratories

Verrica Pharmaceuticals Inc. is in an anticipatory mode, awaiting a 13 July action date for VP-102, its formulation of cantharidin that is in position to become the first approved therapy in the US f

The Australian stem cell and regenerative medicine venture Cynata Therapeutics appears close to being acquired by Japan's Sumitomo Dainippon Pharma Co. Ltd. (SDP), as the companies confirm that nego

Four anti-PD-1 antibodies are already approved in China and the tally keeps going up. Jiangsu Hengrui Medicine Co. Ltd. has become the latest developer to get approval for its product in the class,

Sun Pharmaceutical Industries Ltd. has joined a flock of Indian firms putting the pedal to the metal in China amid evolving regulations and emerging opportunities for growth in the world’s second lar